Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dermatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dermatology Other
    Topical Cream Effective Against Cetuximab-Induced Acne-Like Rash: Presented at ESMO-GI - (DGDispatch)
    Study Characterises Eczema Patients Most at Risk for Dangerous Viral Infections - (DGNews)
    Topical Fluorouracil Reduces Number of Actinic Keratoses, Improves Skin Damage - (DGNews)
    Actinic Keratoses Responsible for More Cancer Types Than Once Believed - (DGNews)
    Oral Linezolid as Effective as Intravenous Vancomycin in Treating MRSA in Complicated Skin and Soft Tissue Infections: Presented at ECCMID - (DGDispatch)

    News archive

     Recent webcasts/CME - Dermatology Other
      The Prevention and Treatment of Pressure Ulcers
      Contemporary Options for the Management of Scars
      Pediatric and Adolescent Sports-Related Injuries and Ailments
      Surgery: Current Challenges in Surgery: Complicated Skin and Soft Tissue Infections
      The Wound Healing Process

      Webcasts/CME archive

       Recent cases - Dermatology Other
        A Patient with Prickling Boils
        Acute Generalized Exanthematous Pustulosis (AGEP) Triggered by a Spider Bite
        A 72-Year-Old Man with a Purpuric Rash
        The First Case of Isolated Facial Cutanenous Leishmaniasis in a Down Syndrome Infant: A Case Report and Review of the Literature
        Bullous Dermatosis

        Cases archive
          




        my personal edition > dermatology other > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Use of Skin Products Containing Numbing Ingredients (Topical Anesthetic Drugs) for Cosmetic Procedures and Potential Life-Threatening Side Effects

        BETHESDA, MD -- February 7, 2007 -- FDA informed consumers and healthcare professionals of the potential hazards of using skin numbing products containing topical anesthetic drugs such as lidocaine, tetracaine, benzocaine, and prilocaine in a cream, ointment, or gel.

        Numbing products are widely used to numb the skin for medical and cosmetic procedures, and to relieve pain, burning and itching due to a variety of medical conditions. FDA has approved many of these products for these uses. Some of these products must be prescribed by a doctor, others may be purchased without a prescription.

        FDA is aware that use of these products before a cosmetic procedure may not be supervised by trained health professionals. Without this supervision, a patient may apply large amounts of the numbing product to their skin, which can cause life-threatening side effects and death. If a skin numbing product is prescribed or recommended for a procedure, consumers should do the following:

        - use a topical anesthetic approved by the FDA.
        - use a topical anesthetic that contains the lowest amount of anesthetic drugs possible that will relieve pain.
        - ask for instructions from your doctor on how to safely use the topical anesthetic.


        SOURCE: Food and Drug Administration



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send